Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
[This corrects the article DOI: 10.1016/j.heliyon.2024.e36532.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169266 | PMC |
| http://dx.doi.org/10.1016/j.heliyon.2025.e43247 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases" [Heliyon Volume 10, Issue 16, August 2024, Article e36532].
Heliyon
May 2025
Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, 253 Gongye Dadao, Guangdong, 510280, Guangzhou, China.
[This corrects the article DOI: 10.1016/j.heliyon.
View Article and Find Full Text PDFCorrigendum to "Prognostic Expression Signature of , , and Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90].
Eur Urol Open Sci
July 2025
Translational Genomics and Targeted Therapeutics in Solid Tumours Lab, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
[This corrects the article DOI: 10.1016/j.euros.
View Article and Find Full Text PDFCorrigendum to "Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium" [Neoplasia 59 (2025 Dec 4) 101085].
Neoplasia
August 2025
Center for Prevention and Therapy of Gynecological Cancers, Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ROC; Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan, ROC; Department of Obstetrics & Gynecology, Hualien Tzu
Corrigendum to "Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients" [Eur. Urol. Oncol. 7 (2024) 954-964].
Eur Urol Oncol
May 2025
Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clínic, Barcelona, Spain; Uro-Oncology Unit, Hospital Clí
Corrigendum: co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside , and mutations.
Front Oncol
September 2024
Institute of Pathology, Leipzig University, Leipzig, Germany.
[This corrects the article DOI: 10.3389/fonc.2024.
View Article and Find Full Text PDF